Sexually Transmitted Diseases · 2008 · 53 citations · 18 references
PharmacyGynecologyPharmacotherapyReproductive MedicineWomen's HealthWomen's Health PharmacotherapyAntiretroviral TherapyVaginal Dosage FormsClinical Laboratory EvaluationColposcopic DiagnosisDaily DosingLaboratory Test EvaluationRandomized Safety EvaluationVaginal GelsVaginal MicrobicidesVaginal Safety
GOAL: This study evaluated the effect of a single dose and 5 additional consecutive daily doses of UC781 gel at concentrations of 0.1%, 0.25%, 1.0%, and 0% on urogenital irritation. STUDY DESIGN: Forty-eight healthy sexually abstinent women were randomly assigned to 1 of 4 groups. METHODS: Urogenital irritation was assessed by pelvic examination, colposcopy, and reports of genital symptoms at baseline and after 1 and 6 doses. Vaginal health was assessed by wet mount and systemic safety by laboratory evaluation after 1 and 6 doses, and UC781 levels were assessed at baseline and after 6 doses. RESULTS: Some evidence of urogenital irritation was common in all treatment groups and was most often transient and mild. Colposcopic findings were infrequent in the placebo group (8%) and more common in the 3 treatment groups (24%-42%). Edema, which may indicate underlying inflammation, was observed in the vaginal fornix of 2 women exposed to UC781. There was no apparent increase in vaginal infection or clinically significant changes in laboratory values. Two of 12 participants randomized to 1% UC781 gel had detectable plasma levels that were less than the lower level of quantification. CONCLUSIONS: UC781 was well tolerated in this initial dose ranging safety study when used once daily for 6 days in sexually abstinent women. Five safety/pharmacokinetic studies of UC781 are currently underway in women and men, all utilizing UC781 concentrations less than 1%, with twice-daily dosing in some studies, and all involving careful monitoring of exposed epithelium.
18
Deborah Tien, Roger L. Schnaare, Feirong Kang et al. · AIDS Research and Human Retroviruses · 2005 · 177 citations
James E. Cummins, Jeannette Guarner, Lisa Flowers et al. · Antimicrobial Agents and Chemotherapy · 2007 · 140 citations · Full text
Yven Van Herrewege, Jo Michiels, Jens Van Roey et al. · Antimicrobial Agents and Chemotherapy · 2003 · 137 citations · Full text